Product Program year 2020 Source: CMS Open Payments

Infinity

Device Elekta Linear Accelerator

Open in the dashboard

General payments

$7,962,256

211 payments

Research payments

$0

0 payments

Through program year 2020, $7,962,256 in general payments and $0 in research payments were reported against Infinity (Elekta Linear Accelerator).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $2,074,942 58
2019 General $5,887,314 153

Breakdown

Who paid General payments · program years 2019–2020
  1. Elekta Limited $7,653,926 12 payments
  2. Elekta, Inc. $99,531 185 payments
  3. Nucletron Operations B.V. $73,835 5 payments
  4. Elekta Instrument Shanghai Ltd $60,000 1 payment
  5. Nucletron B.V. $58,817 6 payments
  6. Elekta Instrument AB $16,147 2 payments
Top recipients General payments · program year 2020
  1. Beaumont Health - Grosse Pointe Teaching hospital · MI $1,971,224 95% · 3 payments
  2. Ut Md Anderson Cancer Center Teaching hospital · TX $28,817 1% · 3 payments
  3. Vivek Mehta Radiation Oncology · Seattle, WA $27,750 1% · 2 payments
  4. Johns Hopkins Bayview Med. Ctr. Teaching hospital · MD $25,085 1% · 1 payment
  5. Swedish Medical Center Teaching hospital · WA $15,000 <1% · 1 payment

The top 5 of 43 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Radiation Oncology Radiology $31,589 99% · 36 practitioners
  2. Neurological Surgery $158 <1% · 1 practitioner
  3. Urology $69 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Michigan $1,971,263 95% · 2 recipients
  2. Washington $42,774 2% · 3 recipients
  3. Texas $29,052 1% · 4 recipients
  4. Maryland $26,585 1% · 2 recipients
  5. California $3,450 <1% · 7 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

211 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record